NO992472L - FremgangsmÕte for Õ diagnostisere metabolske bensykdommer - Google Patents

FremgangsmÕte for Õ diagnostisere metabolske bensykdommer

Info

Publication number
NO992472L
NO992472L NO992472A NO992472A NO992472L NO 992472 L NO992472 L NO 992472L NO 992472 A NO992472 A NO 992472A NO 992472 A NO992472 A NO 992472A NO 992472 L NO992472 L NO 992472L
Authority
NO
Norway
Prior art keywords
ocif
metabolic bone
diagnosing metabolic
antibodies recognizing
arthrosis
Prior art date
Application number
NO992472A
Other languages
English (en)
Norwegian (no)
Other versions
NO992472D0 (no
Inventor
Kazuki Yano
Fumie Kobayashi
Masaaki Goto
Naohiro Washida
Eisuke Tsuda
Kanji Higashio
Yoshiji Yamada
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of NO992472D0 publication Critical patent/NO992472D0/no
Publication of NO992472L publication Critical patent/NO992472L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
NO992472A 1997-09-24 1999-05-21 FremgangsmÕte for Õ diagnostisere metabolske bensykdommer NO992472L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27647597 1997-09-24
PCT/JP1998/003421 WO1999015691A1 (en) 1997-09-24 1998-07-31 Method for diagnosing bone dysbolism

Publications (2)

Publication Number Publication Date
NO992472D0 NO992472D0 (no) 1999-05-21
NO992472L true NO992472L (no) 1999-05-21

Family

ID=17569976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992472A NO992472L (no) 1997-09-24 1999-05-21 FremgangsmÕte for Õ diagnostisere metabolske bensykdommer

Country Status (16)

Country Link
US (2) US6693175B2 (de)
EP (1) EP0974671B1 (de)
JP (1) JP4268684B2 (de)
KR (1) KR100547395B1 (de)
CN (1) CN1183159C (de)
AT (1) ATE328281T1 (de)
AU (1) AU739304B2 (de)
CA (1) CA2269114A1 (de)
DE (1) DE69834719D1 (de)
HU (1) HUP0002062A3 (de)
IL (1) IL129535A (de)
NO (1) NO992472L (de)
NZ (1) NZ335759A (de)
RU (1) RU2203497C2 (de)
WO (1) WO1999015691A1 (de)
ZA (1) ZA986974B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
PL347559A1 (en) 1998-10-28 2002-04-08 Snow Brand Milk Products Co Ltd Remedies for bone metabolic errors
JP3709332B2 (ja) * 2000-09-14 2005-10-26 株式会社エーシーバイオテクノロジーズ 骨粗鬆症の診断および／または骨粗鬆症骨折リスクの予測の方法
WO2002062990A1 (fr) * 2001-02-07 2002-08-15 Sankyo Company, Limited Anticorps et utilisation de cet anticorps
WO2002079256A1 (fr) * 2001-03-26 2002-10-10 Sankyo Company, Limited Anticorps et son utilisation
MXPA03008895A (es) * 2001-04-03 2005-03-07 Nestle Sa Osteoprotegerina de la leche y sus uso.
EP1270015A3 (de) * 2001-06-29 2004-02-25 Sankyo Company Limited Ein Komplex enthaltend OCIF und einem Polysaccharid
EP1482978A1 (de) * 2002-03-01 2004-12-08 Sankyo Company, Limited Pharmazeutische zusammensetzung enthaltend osteoklastogenesishemmungsfaktor
US7279451B2 (en) 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
AU2002343870A1 (en) * 2002-11-07 2004-06-07 Kumamoto Technology And Industry Foundation Transgenic mammal carrying ganp and utilization thereof
KR100545064B1 (ko) * 2003-05-26 2006-01-24 김현기 인간 원암단백질에 특이적인 항체를 포함하는 간경변증진단 키트
RU2261661C1 (ru) * 2004-02-11 2005-10-10 Белых Елена Викторовна Способ прогнозирования переломов кости у женщин, больных ревматоидным артритом
RU2268655C2 (ru) * 2004-03-09 2006-01-27 Государственное учреждение "Нижегородский научно-исследовательский институт гигиены и профпатологии Министерства здравоохранения Российской Федерации" Способ оценки риска развития аллергодерматозов
RU2271007C2 (ru) * 2004-04-28 2006-02-27 Дмитрий Владимирович Пешехонов Способ исследования сыворотки крови для фармакологической коррекции при остеопорозе
EP2024005A4 (de) * 2006-05-17 2013-01-30 Univ New York State Res Found Biomechanisches verfahren zur behandlung von fettleibigkeit und diabetes
RU2358655C2 (ru) * 2007-08-20 2009-06-20 Федеральное государственное учреждение "Уральский научно-исследовательский институт травматологии и ортопедии им. В.Д. Чаклина" Федерального агентства по высокотехнологичной медицинской помощи" Способ диагностики иммобилизационного остеопороза
RU2429476C1 (ru) * 2010-04-22 2011-09-20 Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (ГУ МОНИКИ им. М.Ф. Владимирского) Способ диагностики артроза
WO2012051495A2 (en) 2010-10-15 2012-04-19 The Research Foundation Of State University Of New York Compositions and methods for enhancing the biological response to chemical agents and physical stimuli
RU2524616C1 (ru) * 2013-01-21 2014-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ВГМУ Минздрава России) Способ диагностики ранней стадии ревматоидного артрита
GB201302257D0 (en) 2013-02-08 2013-03-27 Nobel Biocare Services Ag Method for measuring bone loss rate
CN106405064B (zh) * 2016-08-30 2018-10-26 嘉兴行健生物科技有限公司 一种40岁以上女性骨转换率的评估方法
CN109540818A (zh) * 2018-12-21 2019-03-29 云南农业大学 一种基于钙、磷血液生化标记选育武定鸡的方法
CN113621060B (zh) * 2020-05-07 2023-07-04 浙江瑞硕生物技术有限公司 一种opg抗体对及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
AU645742B2 (en) * 1988-10-24 1994-01-27 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
EP0513334A4 (en) 1990-11-30 1993-08-04 Celtrix Laboratories, Inc. Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2068389A1 (en) 1991-05-13 1992-11-14 Masahiko Sato Method for inhibiting bone resorption
MX9204303A (es) 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5366859A (en) * 1991-10-31 1994-11-22 Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis
RU2046600C1 (ru) * 1992-07-28 1995-10-27 Саратовский научно-исследовательский институт травматологии и ортопедии Способ диагностики травматических повреждений тазобедренного сустава
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
WO1995007935A1 (en) 1993-09-14 1995-03-23 Merck & Co., Inc. cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE
AU2753595A (en) * 1994-06-27 1996-01-19 Snow Brand Milk Products Co., Ltd. Novel protein and process for producing the same
AU4440496A (en) 1995-02-10 1996-08-22 Smithkline Beecham Corporation Use of src SH2 specific compounds to treat a bone resorption disease
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996028546A1 (en) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor
WO1997000318A1 (en) 1995-06-07 1997-01-03 Osteosa Inc. Osteoclast growth regulatory factor
AU5985996A (en) 1995-06-07 1997-01-15 Osteosa Inc. Osteoclast growth regulatory factor
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
JPH1057071A (ja) 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
US5830850A (en) * 1996-08-28 1998-11-03 Mount Sinai School Of Medicine Of The City Of New York Methods for the treatment of bone resorption disorders, including osteoporosis
EP0951546A2 (de) 1996-12-20 1999-10-27 The Board Of Regents, The University Of Texas System Zusammensetzungen und verfahren zur verwendung von osteoklasthemmenden faktoren
PT951551E (pt) 1996-12-23 2008-10-28 Immunex Corp Ligando para receptor activador de nf-kb, ligando membro da superfamília de tnf
US5843678A (en) 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins

Also Published As

Publication number Publication date
EP0974671A8 (de) 2002-07-03
IL129535A0 (en) 2000-02-29
NZ335759A (en) 2002-02-01
AU8461798A (en) 1999-04-12
US20040033533A1 (en) 2004-02-19
US20020004207A1 (en) 2002-01-10
NO992472D0 (no) 1999-05-21
KR20000068916A (ko) 2000-11-25
CN1183159C (zh) 2005-01-05
ATE328281T1 (de) 2006-06-15
EP0974671B1 (de) 2006-05-31
DE69834719D1 (de) 2006-07-06
WO1999015691A1 (en) 1999-04-01
HUP0002062A2 (hu) 2000-10-28
AU739304B2 (en) 2001-10-11
EP0974671A1 (de) 2000-01-26
JP4268684B2 (ja) 2009-05-27
ZA986974B (en) 1999-02-04
CN1239515A (zh) 1999-12-22
HUP0002062A3 (en) 2002-09-30
US6998242B2 (en) 2006-02-14
IL129535A (en) 2003-07-06
RU2203497C2 (ru) 2003-04-27
US6693175B2 (en) 2004-02-17
KR100547395B1 (ko) 2006-02-01
EP0974671A4 (de) 2004-10-22
CA2269114A1 (en) 1999-03-24

Similar Documents

Publication Publication Date Title
NO992472D0 (no) FremgangsmÕte for Õ diagnostisere metabolske bensykdommer
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
DE59008278D1 (de) Spezifische Antikörper gegen Troponin T, ihre Herstellung und Verwendung in einem Reagenz zur Bestimmung von Herzmuskelnekrosen.
DE69126248D1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
RU99113447A (ru) Способ диагностики метаболических костных заболеваний
ATE120549T1 (de) Verfahren zur bestimmung von hiv-antikörpern.
ATE142646T1 (de) Verfahren zur immunologischen bestimmung des carboxyterminalen peptids von typ-i-prokollagen
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
BR9607854A (pt) Processos para a medição da taxa de degradação de uma proteína do corpo e para obtenção de informação referente à degradação de proteína em um paciente utilização de um isômero sintético de um peptídeo e de um anticorpo anticorpo capa de células análogo de peptídeo sintético e kit de análise para utilização em um processo de análise
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
EP1245957A3 (de) Methode zur Konzentrationsbestimmung von Ceruloplasmin in einem Blutflecken mittels enzymgekoppeltem Immunosorbent-Assay oder mittels dissoziationsverstärktem, zeitaufgelöstem Immunofluoreszenzassay, sowie Kit zum Auffinden der Wilson-Krankheit und Diagnosemethode für letztere
EP0738735A3 (de) Typ I Prokollagen aminoterminales Propeptid, dessen Antikörper und Testverfahren unter Verwendung davon
EP0245052A3 (de) Feststellung einer Entzündung und Antikörper dazu
ES2094784T3 (es) Procedimiento para la determinacion de un analito.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
FR2700011B1 (fr) Détection de la mucoviscidose ou d'une mutation du gêne CFTR au moyen d'un dosage de la PAP.
ATE180894T1 (de) Verwendung von polyklonalen humanen anti-htg- autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
WO1990008956A1 (en) Detection of human tissue factor activator
ATE302949T1 (de) Knorpelresorptionsassays
DE69637466D1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin
RU97106519A (ru) Способ определения метадона в биологических жидкостях

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application